<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="0" ids="38462">acetylcholinesterase inhibitor</z:chebi> <z:chebi fb="0" ids="4696">donepezil hydrochloride</z:chebi> improves cognitive function in patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Given <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>'s important actions on the heart, we undertook a retrospective cohort investigation to assess whether <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi> usage affects cardiovascular mortality </plain></SENT>
<SENT sid="2" pm="."><plain>In patients treated with <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi>, hazard ratios for total and cardiovascular mortality were 0.68 (P = 0.045, 95% confidence interval 0.46-0.99) and 0.54 (P = 0.042, 95% confidence interval 0.30-0.98), respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The apparent survival benefit in <z:chebi fb="0" ids="53289,53290,53292">donepezil</z:chebi>-treated patients should not be overinterpreted </plain></SENT>
<SENT sid="4" pm="."><plain>Prospective clinical trials are warranted </plain></SENT>
</text></document>